In 2009, Rick Diamond funded The Neuromyelitis Optica (NMO) Clinical and Research Program at the Djavad Mowafaghian Centre for Brain Health is Canada’s only NMO program that is focused on clinical service
with a research component.
What is NMO? Neuromyelitis optica (NMO) is a chronic and unpredictable disease that has significant impact not only on you, but also on your family members and friends, as you try to cope with the
disease and the changes it may bring.
The NMO Clinic and Research Program, under the direction of Dr. Anthony Traboulsee, is focused on finding the cause and improving the treatment of NMO. It strives to raise ongoing awareness and to educate and
disseminating information about NMO to patients, the public, and healthcare professionals.
THE GOALS OF THE NMO CLINIC AND RESEARCH PROGRAM ARE:
- Improve the accuracy of diagnosis
- Start preventative treatment as early as possible and treat severe relapses rapidly
- Research NMO to improve our understanding and develop new preventative treatments
- Educate patients, families and healthcare professionals about NMO
- Advocate with government, hospitals and the MS Society for NMO resources
- Establish national
guidelines for NMO treatment
For more information please visit Centre For Brain Health
